Roundup

Overview

Roundup appears in this episode as the pesticide product at the center of Monsanto/Bayer litigation and Supreme Court argument over federal label preemption.

Current Profile

The source frames Roundup through the tension between EPA labeling and state product-liability claims. David Friedberg says the Environmental Protection Agency determined Roundup does not cause cancer for labeling purposes, while plaintiffs continue to bring state failure-to-warn suits. The product therefore becomes a test case for how much federal regulatory approval shields manufacturers from state-law liability.

Key Characteristics

• Pesticide product linked to Monsanto and Bayer.
• Discussed through failure-to-warn litigation.
• Central to an EPA-labeling versus state-law preemption dispute.
• Used as an example of how scientific, regulatory, and legal determinations can diverge.

Evidence

• Regulatory frame: OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze says EPA labeling is central to the argument.
• Litigation frame: OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze says Bayer has paid, reserved, and still faces many Roundup-related cases.

Qualifications

The source does not retry the scientific causation evidence. It explicitly frames the Supreme Court argument as legal interpretation rather than fact-finding.

What Changed

• Created Roundup as the product node for the pesticide-label preemption dispute.

Relationships

• Monsanto - original company identity associated with the product.
• Bayer - owner facing litigation exposure.
• Environmental Protection Agency - regulator whose label position is central.
• Product Liability Federal Preemption - legal question raised by the case.